The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
From Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease (2004) · cites this paper as [24]
In the citing paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
From Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease (2004) · cites this paper as [24]
In the citing paper
“Several studies have shown a strong relationship among nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes mellitus.1–3”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [2]
In the citing paper
“There is now strong evidence that nonalcoholic fatty liver disease has an important role in causing hepatic insulin resistance.1–3,23–27”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [2]
In the citing paper
“There is increasing evidence for a causal relationship between hepatic steatosis and hepatic insulin resistance both in rodent models with hepatic steatosis and in patients with nonalcoholic fatty liver disease (4, 18-25).”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [20]
In the citing paper
“Fatty acid-induced reductions in insulin receptor number and function in the liver (211) may also reduce hepatic insulin clearance (226), causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function (214,227,228).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [226]
In the citing paper
“The associations between liver fat and hepatic insulin resistance have previously been reported by Bajaj et al, 62 who studied 14 type 2 diabetic patients, and by us in nondiabetic subjects 24,39 and type 2 diabetic patients treated with insulin. 36,38”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [39]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 101–200 of 1,023
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 299
Jakobsdottir, G., Xu, J., Molin, G., Ahrné, S., & NYMAN, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080476 · Cited by 295
Misra, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0007 · Cited by 292
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Laaksonen, D. E., NISKANEN, L. K., Nyyss�nen, K., Punnonen, K. R. A., Tuomainen, T., Valkonen, V.-P., Salonen, R. M., & Salonen, J. T. (2004) · Diabetologia · doi:10.1007/s00125-004-1472-x · Cited by 290
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Self-citationKlein, S., Mittendorfer, B., Eagon, J. C., Patterson, B. W., Grant, L. M., Feirt, N. M., Seki, E., Brenner, D. A., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 292
Gastaldelli, A., Harrison, S. A., Belfort-Aguilar, R., Hardies, L. J., Balas, B., Schenker, S., & Cusi, K. (2009) · Hepatology · doi:10.1002/hep.23116 · Cited by 285
Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 287
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Wang, M. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-3 · Cited by 284
Heni, M., Machann, J., Staiger, H., Schwenzer, N. F., Peter, A., Schick, F., Claussen, C. D., Stefan, N., Häring, H., & Fritsche, A. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1073 · Cited by 278
Kantartzis, K., Thamer, C., Peter, A., Machann, J., Schick, F., Schraml, C., Konigsrainer, A., Konigsrainer, I., Krober, S., Niess, A., et al. (2009) · Gut · doi:10.1136/gut.2008.151977 · Cited by 273
Tiikkainen, M., Bergholm, R., Vehkavaara, S., Rissanen, A., Häkkinen, A.-M., Tamminen, M., Teramo, K., & Yki-Järvinen, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.701 · Cited by 271
Self-citationStanhope, K. L., & Havel, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2b24a · Cited by 274
Fat in the liver and insulin resistance
Yki‐Järvinen, H. (2005) · Annals of Medicine · doi:10.1080/07853890510037383 · Cited by 269
Self-citationHepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models
den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000116217.57583.6e · Cited by 260
Kupffer cell activation is a causal factor for hepatic insulin resistance
Lanthier, N., Molendi‐Coste, O., Horsmans, Y., van Rooijen, N., Cani, P. D., & Leclercq, I. A. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00391.2009 · Cited by 269
Non-invasive means of measuring hepatic fat content
Mehta, S. R., Thomas, E. L., Bell, J. D., Johnston, D. G., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3476 · Cited by 259
Jones, H., Sprung, V. S., Pugh, C. J. A., Daousi, C., Irwin, A., Aziz, N., Adams, V. L., Thomas, E. L., Bell, J. D., Kemp, G. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1382 · Cited by 256
Luukkonen, P. K., Dufour, S., Lyu, K., Zhang, X., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., Shulman, G. I., & Yki‐Järvinen, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922344117 · Cited by 261
Self-citationStandardized assessment of whole body adipose tissue topography by MRI
Machann, J., Thamer, C., Schnoedt, B., Haap, M., Haring, H., Claussen, C., Stumvoll, M., Fritsche, A., & Schick, F. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20292 · Cited by 266
Kotronen, A., Seppänen‐Laakso, T., Westerbacka, J., Kiviluoto, T. A., Arola, J. T., Ruskeepää, A., Orešič, M., & Yki‐Järvinen, H. (2008) · Diabetes · doi:10.2337/db08-1074 · Cited by 253
Self-citationNonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Fructose as a key player in the development of fatty liver disease
Basaranoglu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1166 · Cited by 235
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Kahleova, H., Belinova, L., Malinska, H., Oliyarnyk, O., Trnovska, J., Skop, V., Kazdova, L., Dezortova, M., Hajek, M., Tura, A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3253-5 · Cited by 229
Metabolic syndrome and non-alcoholic fatty liver disease
Almeda‐Valdés, P., Ramos, D. C., & Aguilar-Salinas, C. A. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31822-8 · Cited by 234
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D. P., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 223
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 229
Inhibition of Hypothalamic Inflammation Reverses Diet-Induced Insulin Resistance in the Liver
Milanski, M., Arruda, A. P., Coope, A., Ignácio-Souza, L. M., Nuñez, C. E. C., Roman, E. A., Romanatto, T., Pascoal, L. B., Caricilli, A. M., Torsoni, M. A., et al. (2012) · Diabetes · doi:10.2337/db11-0390 · Cited by 233
Pathogenesis of nonalcoholic steatohepatitis
Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 233
Mohan, V., Syed, F., Deepa, M., Ravikumar, R., & Pitchumoni, C. S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.039 · Cited by 226
Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese Adolescents
D’Adamo, E., Cali, A. M. G., Weiss, R., Santoro, N., Pierpont, B. M., Northrup, V. S., & Caprio, S. (2010) · Diabetes Care · doi:10.2337/dc10-0284 · Cited by 218
Larson‐Meyer, D. E., Newcomer, B. R., Heilbronn, L. K., Vólaufová, J., Smith, S. R., Alfonso, A. J., LeFevre, M. L., Rood, J. C., Williamson, D. A., Ravussin, É., et al. (2008) · Obesity · doi:10.1038/oby.2008.201 · Cited by 215
Wang, C., Ou, H., Chen, M.-F., Chang, T., & Chang, C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000297 · Cited by 215
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Lin, H., Yu, I.-C. I., Wang, R.-S., Chen, Y., Liu, N.-C., Altuwaijri, S., Hsu, C., Ma, W., Jokinen, J. D., Sparks, J. D., et al. (2008) · Hepatology · doi:10.1002/hep.22252 · Cited by 212
Perseghin, G., Lattuada, G., COBELLI, F. D., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Maschio, A. D., et al. (2007) · Hepatology · doi:10.1002/hep.21983 · Cited by 213
Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A. D., Tiniakos, D., Hollingsworth, K. G., Taylor, R., Day, C. P., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.031 · Cited by 209
Shojaee‐Moradie, F., Baynes, K., Pentecost, C., Bell, J. D., Thomas, E. L., Jackson, N. C., Stolinski, M., Whyte, M., Lovell, D., Bowes, S. B., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0498-7 · Cited by 209
Effect of liver fat on insulin clearance
Kotronen, A., Vehkavaara, S., Seppälä-Lindroos, A., Bergholm, R., & Yki-Järvinen, H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2007 · Cited by 202
Self-citationAdipose tissue distribution is different in type 2 diabetes
Gallagher, D., Kelley, D. E., Yim, J., Spence, N., Albu, J., Boxt, L. M., Pi‐Sunyer, F. X., & Heshka, S. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26955 · Cited by 206
Adiels, M., Westerbacka, J., Soro‐Paavonen, A., Häkkinen, A. ‐., Vehkavaara, S., CASLAKE, M. J., Packard, C. J., Olofsson, S.-O., Yki‐Järvinen, H., Taskinen, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 197
Self-citationRaubenheimer, P. J., Nyirenda, M., & Walker, B. R. (2006) · Diabetes · doi:10.2337/db06-0097 · Cited by 199
Kotronen, A., Velagapudi, V. R., Yetukuri, L., Westerbacka, J., Bergholm, R., Ekroos, K., Makkonen, J., Taskinen, M.-R., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1282-2 · Cited by 198
Self-citationThematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity
Koutsari, C., & Jensen, M. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600011-jlr200 · Cited by 201
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 204
Kim, S. P., Ellmerer, M., Citters, G. W. V., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2453 · Cited by 195
Toledo, F. G. S., Sniderman, A. D., & Kelley, D. E. (2006) · Diabetes Care · doi:10.2337/dc06-0455 · Cited by 196
Pathogenesis and pathophysiology of the cardiometabolic syndrome
Kirk, E. P., & Klein, S. (2009) · The Journal of Clinical Hypertension · doi:10.1111/j.1559-4572.2009.00054.x · Cited by 195
Fabbrini, E., Mohammed, B. S., Korenblat, K. M., Magkos, F., McCrea, J., Patterson, B. W., & Klein, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2622 · Cited by 192
Guiu, B., Petit, J., Loffroy, R., Salem, D. B., Aho, S., Masson, D., Hillon, P., Krause, D., & Cercueil, J. (2008) · Radiology · doi:10.1148/radiol.2493080217 · Cited by 192
Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., & Meli, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.002 · Cited by 197
Stefanović-Račić, M., Perdomo, G., Mantell, B. S., SIPULA, I. J., Brown, N. F., & O'Doherty, R. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2007 · Cited by 197
Musso, G., Gambino, R., Biroli, G., Carello, M., Fagà, E., Pacini, G., Michieli, F. D., Cassader, M., Durazzo, M., Rizzetto, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00297.x · Cited by 191
Kim, H., Haluzı́k, M., Shyr, Z. A., Yau, D., Joseph, J. W., Fernandez, A. M., Reitman, M. L., Yakar, S., STANNARD, B. S., Héron‐Milhavet, L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1770 · Cited by 192
Sutinen, J., Häkkinen, A., Westerbacka, J., Seppälä‐Lindroos, A., Vehkavaara, S., Halavaara, J. T., Järvinen, A., Ristola, M. A., & Yki‐Järvinen, H. (2003) · Antiviral Therapy · doi:10.1177/135965350300800303 · Cited by 189
Self-citationHwang, J.-H., Stein, D. T., Barzilai, N., Cui, M.-H., Tonelli, J., Kishore, P., & Hawkins, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2006 · Cited by 188
Hepatic Steatosis as a Marker of Metabolic Dysfunction
Fabbrini, E., & Magkos, F. (2015) · Nutrients · doi:10.3390/nu7064995 · Cited by 192
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Valenti, L. V. C., Rametta, R., Dongiovanni, P., Maggioni, M., Fracanzani, A. L., Zappa, M. A., Lattuada, E., Roviaro, G., & Fargion, S. R. (2008) · Diabetes · doi:10.2337/db07-0714 · Cited by 186
Ahmed, M. H., & Byrne, C. D. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.009 · Cited by 185
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Cintra, D. E., Pauli, J. R., ARAUJO, E. P. D., Moraes, J. C., de Souza, C. T., Milanski, M., Morari, J., Gambero, A., Saad, M. J. A., & Velloso, L. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.017 · Cited by 186
Goudriaan, J. R., Dahlmans, V. E. H., Teusink, B., Ouwens, D. M., Febbraio, M., Maassen, J. A., Romijn, J. A., Havekes, L. M., & Voshol, P. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300143-jlr200 · Cited by 191
Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B–null mice
Choi, Y. H., Park, S., Hockman, S. C., Zmuda‐Trzebiatowska, E., Svennelid, F., Haluzı́k, M., Gavrilova, O., Ahmad, F., Pepin, L., Napolitano, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24867 · Cited by 187
Abdominal Obesity and Fatty Liver
Jakobsen, M. U., Berentzen, T. L., Sørensen, T. I. A., & Overvad, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm002 · Cited by 185
Westerbacka, J., Yki‐Järvinen, H., Vehkavaara, S., Häkkinen, A., Andrew, R., Wake, D. J., Seckl, J. R., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030596 · Cited by 176
Self-citationThe Emerging Functions of UCP2 in Health, Disease, and Therapeutics
Mattiasson, G., & Sullivan, P. G. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1 · Cited by 181
Cruz, M. L., Shaibi, G. Q., Weigensberg, M. J., Spruijt‐Metz, D., Ball, G. D. C., & Goran, M. I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092625 · Cited by 183
Nonalcoholic fatty liver disease and polycystic ovary syndrome
Vassilatou, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8351 · Cited by 176
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Valenti, L., Bugianesi, E., Pajvani, U., & Targher, G. (2016) · Liver International · doi:10.1111/liv.13185 · Cited by 171
Steven (2016) · doi:10.2337/dc15-0750 · Cited by 171
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P. V., Nygrén, H., Arola, J. T., Castillo, S., Mattila, I. M., Hakkarainen, A., Borra, R., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 173
Self-citationConcurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis
Gauthier, M., Couturier, K., Latour, J.-G., & Lavoie, J.-M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01164.2002 · Cited by 167
The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes
Ou, H., Wang, C., Yang, Y., Chen, M.-F., & Chang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062561 · Cited by 170
Glucose dysregulation and hepatic steatosis in obese adolescents
Cali, A. M. G., de Oliveira, A. M., Kim, H.-J., Chen, S., Reyes‐Múgica, M., Escalera, S., Dziura, J., Taksali, S. E., Kursawe, R., Shaw, M. M., et al. (2009) · Hepatology · doi:10.1002/hep.22858 · Cited by 163
ter Horst, K. W., Gilijamse, P. W., Versteeg, R. I., Ackermans, M. T., Nederveen, A. J., la Fleur, S. E., Romijn, J. A., Nieuwdorp, M., Zhang, D., Samuel, V. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.035 · Cited by 166
Role of ChREBP in hepatic steatosis and insulin resistance
Denechaud, P., Dentin, R., Girard, J. R., & Postic, C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.084 · Cited by 171
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Machann, J., Thamer, C., Schnoedt, B., Stefan, N., Haring, H., Claussen, C. D., Fritsche, A., & Schick, F. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20825 · Cited by 162
Ma, X., Lee, P., Chisholm, D. J., & James, D. E. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00001 · Cited by 167
Ruiz, R., Jideonwo, V. N., Ahn, M., Surendran, S., Tagliabracci, V. S., Hou, Y., Gamble, A., Kerner, J., Irimia, J. M., Puchowicz, M. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541110 · Cited by 167
(2007) · doi:10.1139/h06-102 · Cited by 160
Lawlor, D. A., Sattar, N. A., Smith, G. D., & Ebrahim, S. B. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi125 · Cited by 161
Skytte, M. J., Samkani, A., Petersen, A. D., Thomsen, M. N., Astrup, A. V., Chabanova, E., Frystyk, J., Holst, J. J., Thomsen, H. S., Madsbad, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4956-4 · Cited by 163
The clinical biochemistry of obesity.
Sikaris, K. A. (2004) · PubMed Central · Cited by 158
Sevastianova, K., Kotronen, A., Gastaldelli, A., Perttilä, J., Hakkarainen, A., Lundbom, J., Suojanen, L.-U., Orho‐Melander, M., Lundbom, N. M. I., Ferrannini, E., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.012369 · Cited by 158
Self-citationMachann, J., Thamer, C., Schnödt, B., Stefan, N., Stümvoll, M., Häring, H.-U., Claussen, C. D., Schick, F., & Fritsche, A. (2005) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-005-0104-x · Cited by 157
Eckard, C. S., Cole, R. E., Lockwood, J., Torres, D. M., Williams, C. D., Shaw, J. C., & Harrison, S. A. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13484078 · Cited by 155
Visceral adipose tissue area is an independent risk factor for hepatic steatosis
Park, B. J., Kim, Y. J., Kim, D., Kim, W. K., Jung, Y. J., Yoon, J., Kim, C. Y., Cho, Y. M., Kim, S. H., Lee, K. B., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05212.x · Cited by 154
Fatty liver in familial hypobetalipoproteinemia
Tanoli, T., Yue, P., Yablonskiy, D. A., & Schonfeld, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300508-jlr200 · Cited by 161
Simonen, P. P., Kotronen, A., Hallikainen, M., Sevastianova, K., Makkonen, J., Hakkarainen, A., Lundbom, N. M. I., Miettinen, T. A., Gylling, H. K., & Yki‐Järvinen, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.037 · Cited by 157
Self-citationNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Yki‐Järvinen, H. (2015) · Nutrients · doi:10.3390/nu7115454 · Cited by 155
Self-citationFatty acids and insulin resistance in muscle and liver
Kovacs, P. L., & Stümvoll, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.003 · Cited by 158
Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
Bradley, D. P., Magkos, F., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.114 · Cited by 154
The Glucocorticoid Receptor Controls Hepatic Dyslipidemia through Hes1
Lemke, U., Krones, A., Díaz, M. B., Narvekar, P., Ziegler, A., Vegiopoulos, A., Cato, A. C. B., Böhl, S., Klingmüller, U., Screaton, R. A., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.001 · Cited by 149
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 152
Fructose consumption: recent results and their potential implications
Stanhope, K. L., & Havel, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05266.x · Cited by 150
Chen, S. C.-C., Tsai, S. P., Jhao, J.-Y., Jiang, W.-K., Tsao, C. K., & Chang, L.-Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04631-7 · Cited by 148
Huang, J., Iqbal, J., Saha, P., Liu, J., Chan, L., Hussain, M. M., Moore, D. D., & Wang, L. (2007) · Hepatology · doi:10.1002/hep.21632 · Cited by 146
Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease
Johnson, N. A., & George, J. (2010) · Hepatology · doi:10.1002/hep.23711 · Cited by 146
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 145
Self-citation
Metadata
- Authors
- Seppala-Lindroos, A.
- Corresponding author
- Seppala-Lindroos, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-07-01
- Volume
- 87
- Issue
- 7
- Pages
- 3023-3028
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W4237246788
- Cited by
- 168
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2020: 2 · 2018: 2 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 13 · 2012: 23
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hepatic lipid accumulation, insulin suppression, glucose production, serum free fatty acids, obesity, insulin resistance, hepatic glucose metabolism, non-obese men
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review